Cargando…

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder

Methylphenidate (MPH) is the most frequently used pharmacological treatment in children with attention-deficit/hyperactivity disorder (ADHD). However, a considerable interindividual variability exists in clinical outcome. Thus, we performed a genome-wide association study of MPH efficacy in 173 ADHD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagerols, Mireia, Richarte, Vanesa, Sánchez-Mora, Cristina, Rovira, Paula, Soler Artigas, María, Garcia-Martínez, Iris, Calvo-Sánchez, Eva, Corrales, Montse, da Silva, Bruna Santos, Mota, Nina Roth, Victor, Marcelo Moraes, Rohde, Luis Augusto, Grevet, Eugenio Horacio, Bau, Claiton Henrique Dotto, Cormand, Bru, Casas, Miguel, Ramos-Quiroga, Josep Antoni, Ribasés, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789875/ https://www.ncbi.nlm.nih.gov/pubmed/29382897 http://dx.doi.org/10.1038/s41598-018-20194-7

Ejemplares similares

Gene-wide Association Study Reveals RNF122 Ubiquitin Ligase as a Novel Susceptibility Gene for Attention Deficit Hyperactivity Disorder
por: Garcia-Martínez, Iris, et al.
Publicado: (2017)

Epigenome-wide association study of attention-deficit/hyperactivity disorder in adults
por: Rovira, Paula, et al.
Publicado: (2020)

Behavioural effects of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis protocol
por: Leffa, Douglas Teixeira, et al.
Publicado: (2018)

Preliminary evidence for association of genetic variants in pri-miR-34b/c and abnormal miR-34c expression with attention deficit and hyperactivity disorder
por: Garcia-Martínez, I, et al.
Publicado: (2016)

Comprehensive analysis of omics data identifies relevant gene networks for Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Cabana-Domínguez, Judit, et al.
Publicado: (2022)

Transcriptomic risk scores for attention deficit/hyperactivity disorder
por: Cabana-Domínguez, Judit, et al.
Publicado: (2023)

Gut microbiota signature in treatment-naïve attention-deficit/hyperactivity disorder
por: Richarte, Vanesa, et al.
Publicado: (2021)

Shared genetic background between children and adults with attention deficit/hyperactivity disorder
por: Rovira, Paula, et al.
Publicado: (2020)

An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder
por: da Silva, Bruna Santos, et al.
Publicado: (2023)

Mendelian randomization analysis for attention deficit/hyperactivity disorder: studying a broad range of exposures and outcomes
por: Soler Artigas, María, et al.
Publicado: (2022)

Attention-deficit/hyperactivity disorder and brain metabolites from proton magnetic resonance spectroscopy: a systematic review and meta-analysis protocol
por: Vidor, Marcos Vinícius, et al.
Publicado: (2021)

Integrative proteomics and pharmacogenomics analysis of methylphenidate treatment response
por: da Silva, Bruna S., et al.
Publicado: (2019)

Insomnia Disorder in Adult Attention-Deficit/Hyperactivity Disorder Patients: Clinical, Comorbidity, and Treatment Correlates
por: Fadeuilhe, Christian, et al.
Publicado: (2021)

Approaching “Phantom Heritability” in Psychiatry by Hypothesis-Driven Gene–Gene Interactions
por: Rovaris, Diego Luiz, et al.
Publicado: (2013)

Exome chip analyses in adult attention deficit hyperactivity disorder
por: Zayats, T, et al.
Publicado: (2016)

Changes in the Mental Health of Children and Adolescents during the COVID-19 Lockdown: Associated Factors and Life Conditions
por: Bosch, Rosa, et al.
Publicado: (2022)

The genetics of attention deficit/hyperactivity disorder in adults, a review
por: Franke, B, et al.
Publicado: (2012)

Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan
por: Vilar-Ribó, Laura, et al.
Publicado: (2023)

The impact of attention-deficit/hyperactivity disorder and specific learning disorders on academic performance in Spanish children from a low-middle- and a high-income population
por: Español-Martín, Gemma, et al.
Publicado: (2023)

Laminar Thickness Alterations in the Fronto-Parietal Cortical Mantle of Patients with Attention-Deficit/Hyperactivity Disorder
por: Hoekzema, Elseline, et al.
Publicado: (2012)

Linking dopamine neurotransmission and neurogenesis: The evolutionary history of the NTAD (NCAM1-TTC12-ANKK1-DRD2) gene cluster
por: Mota, Nina Roth, et al.
Publicado: (2012)

Correction: Laminar Thickness Alterations in the Fronto-Parietal Cortical Mantle of Patients with Attention-Deficit/Hyperactivity Disorder
por: Hoekzema, Elseline, et al.
Publicado: (2013)

Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
por: Buitelaar, Jan K, et al.
Publicado: (2009)

Association of the PLCB1 gene with drug dependence
por: Cabana-Domínguez, Judit, et al.
Publicado: (2017)

Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate
por: Buitelaar, J. K., et al.
Publicado: (2012)

Two-stage case-control association study of dopamine-related genes and migraine
por: Corominas, Roser, et al.
Publicado: (2009)

Reduced fronto-striatal volume in attention-deficit/hyperactivity disorder in two cohorts across the lifespan
por: Cupertino, Renata Basso, et al.
Publicado: (2020)

Genome‐wide analyses of aggressiveness in attention‐deficit hyperactivity disorder
por: Brevik, Erlend J., et al.
Publicado: (2016)

Psychiatric disorders and comorbidity in a Spanish sample of prisoners at the end of their sentence: Prevalence rates and associations with criminal history
por: Pagerols, Mireia, et al.
Publicado: (2023)

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder
por: Safavi, Parvin, et al.
Publicado: (2016)

ADGRL3 (LPHN3) variants predict substance use disorder
por: Arcos-Burgos, Mauricio, et al.
Publicado: (2019)

Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects
por: Gomez-Sanchez, Clara I., et al.
Publicado: (2017)

Glutamate and Synaptic Plasticity Systems and Smoking Behavior: Results from a Genetic Association Study
por: dos Santos, Vanessa Argondizo, et al.
Publicado: (2012)

A Highly Polymorphic Copy Number Variant in the NSF Gene is Associated with Cocaine Dependence
por: Cabana-Domínguez, Judit, et al.
Publicado: (2016)

Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures
por: Mota, Nina Roth, et al.
Publicado: (2020)

Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015)

The impact of psychopathology on academic performance in school-age children and adolescents
por: Pagerols, Mireia, et al.
Publicado: (2022)

Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan
por: Franke, Barbara, et al.
Publicado: (2018)

Searching for ancient balanced polymorphisms shared between Neanderthals and Modern Humans
por: Viscardi, Lucas Henriques, et al.
Publicado: (2018)

The Effects of Methylphenidate on Decision Making in Attention-Deficit/Hyperactivity Disorder
por: DeVito, Elise E., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_t3ufd0ns2vp4c0qkrb1q6km9uv